Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings

American Journal of Tropical Medicine and Hygiene(2020)10.4269/ajtmh.20-0290Source: DataRank Database

Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings is a research paper published in American Journal of Tropical Medicine and Hygiene (2020). On theSindex it has a DataRank of 0. It has been cited 143 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access143 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.29)OA: bronzeTopics (63)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Eric Decloedt ORCID,Emmanuel Bottieau ORCID,Fátima Suleman ORCID,Prisca Olabisi Adejumo ORCID,Nadia A. Sam‐Agudu

Live enrichment

PubMed:32323646 OpenAlex:https://openalex.org/W3018088696

National Institutes of Health

Grant: 5U01AI069521-02

Stellenbosch University Clinical Trial Unit, Cape Town, South Africa

National Institutes of Health

Grant: 1D43TW010937-01A1

University of Pittsburgh HIV-Comorbidities Research Training Program in South Africa

National Institutes of Health

Grant: 1R01HD089866-01

The Adolescent to Adult Patient-centered HIV Transition Study (ADAPT)

National Institutes of Health

Grant: 1R25TW011217-01

African Association for Health Professions Education and Research

FWCI

3.29

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

bronzeLicense: cc-by

journalhttps://www.ajtmh.org/downloadpdf/view/journals/tpmd/102/6/article-p1184.pdf

publisherhttps://www.ajtmh.org/downloadpdf/view/journals/tpmd/102/6/article-p1184.pdf

journalhttps://doi.org/10.4269/ajtmh.20-0290

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32323646

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7253100

Fields of Study

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchPharmacovigilance and Adverse Drug Reactions03 medical and health sciences0302 clinical medicine

MeSH Terms

BetacoronavirusCOVID-19SARS-CoV-2COVID-19 TestingAntimalarialsAntiviral AgentsChloroquineHumansHydroxychloroquinePneumonia, ViralUnited StatesRandomized Controlled Trials as TopicTreatment OutcomePractice Guidelines as TopicAzithromycinCoronavirus InfectionsSample SizeAntirheumatic AgentsClinical Laboratory TechniquesOff-Label UseDrug RepositioningPandemics

Keywords

HydroxychloroquineChloroquineMedicinePandemicIntensive care medicineMalariaRepurposingClinical trialMedical prescriptionHealth careCoronavirus disease 2019 (COVID-19)PharmacologyImmunologyDiseaseEconomic growthInternal medicineInfectious disease (medical specialty)Clinical Laboratory TechniquesSARS-CoV-2Pneumonia, ViralDrug RepositioningCOVID-19Off-Label UseAzithromycinAntiviral AgentsPerspective PieceAntimalarialsBetacoronavirusCOVID-19 TestingAntirheumatic AgentsSample SizePractice Guidelines as TopicHumansCoronavirus InfectionsPandemicsRandomized Controlled Trials as Topic

Sustainable Development Goals

SDG 3: 3. Good health